We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Common Drug Counteracts Treatment Resistance in Patients With Leukemia

News

A new study suggests that a common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML).

Read more
 
Global Efforts To Contain Antibiotic Resistant Infections Under Threat
News

According to the World Health Organization, a weak development pipeline for new antibiotics is undermining efforts to combat drug-resistant infections.

Read more

Progression of Eye and Cardiac Disease Halted by Food Supplement
News

UNIGE researchers have discovered a new gene that causes blindness and
cardiomyopathy. They have also managed to halt the progression of eye disease and treat cardiac disease by administering a food supplement.

Read more

Predicting Melanoma Patients at Risk of Cancer Recurrence
News

Technique reveals that primary melanoma patients with lower T-cell fraction are 2.5 times more likely to have cancer metastasize than patients with higher T-cell fraction.

Read more

 
 
 
 
Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging
Article

In a new study scientists have harnessed advances in proteomics to extensively profile the secretions of senescent cells which are implicated in aging. Their analyses are collated in a database that is now available for researchers in the field.

Read more

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals
Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

Read more

The Importance of Understanding Target–Protein Interactions in Drug Discovery
Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

Read more

Incidence vs Prevalence
Article

In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.

Read more

Complementary Bonds: Strategic Collaboration Between ELRIG and BPS Announced at Pharmacology 2019
Article

A new collaboration was announced Monday between the British Pharmacological Society (BPS) and scientific not-for-profit The European Laboratory Research & Innovation Group (ELRIG) UK at the annual Pharmacology 2019 meeting in Edinburgh, Scotland.

Read more

Advances in High-throughput Screening
Article

Ever since the advent of the multi-well plate, researchers have been pioneering new ways to miniaturize assays for high-throughput screening (HTS). Here, we share two examples that illustrate the power of modern HTS in drug discovery.

Read more